All Pharma News
Halberd`s Patented Drug, LDN+ Trial Under the Four-Company CRADA Contract

Halberd`s Patented Drug, LDN+ Trial Under the Four-Company CRADA Contract
ACCESSWIRE
04 Apr 2024
Share Share
Halberd`s Top Executives Join Forces with Athena GTX CEO Mark Darrah

Halberd`s Top Executives Join Forces with Athena GTX CEO Mark Darrah
ACCESSWIRE
06 Feb 2024
Share Share
Halberd Corporation 2023 Year-End CEO Update and 2024 Goals

Halberd Corporation 2023 Year-End CEO Update and 2024 Goals
ACCESSWIRE
11 Jan 2024
Share Share
Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
ACCESSWIRE
10 Jan 2024
Share Share
Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
ACCESSWIRE
09 Jan 2024
Share Share
Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com

Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com
ACCESSWIRE
13 Dec 2023
Share Share
Halberd Plans to Extend Research Partnership with Mississippi State University

Halberd Plans to Extend Research Partnership with Mississippi State University
ACCESSWIRE
15 Nov 2023
Share Share
Halberd Corporation 2Q23 CEO Letter

Halberd Corporation 2Q23 CEO Letter
ACCESSWIRE
20 Jul 2023
Share Share
Halberd Initial Preclinical Testing Phase at MSU Complete

Halberd Initial Preclinical Testing Phase at MSU Complete
ACCESSWIRE
23 May 2023
Share Share
Halberd Pre-Clinical Test Protocol Approved

Halberd Pre-Clinical Test Protocol Approved
ACCESSWIRE
09 May 2023
Share Share